7 research outputs found
Chiral Phonons with Giant Magnetic Moments in a Topological Crystalline Insulator
We have studied the magnetic response of transverse optical phonons in
PbSnTe films. Polarization-dependent terahertz
magnetospectroscopy measurements revealed Zeeman splittings and diamagnetic
shifts, demonstrating that these phonon modes become chiral in magnetic fields.
Films in the topological crystalline insulator phase () exhibited
magnetic moment values that are larger than those for topologically trivial
films () by two orders of magnitude. Furthermore, the sign of the
effective -factor was opposite in the two phases, which can be explained by
our theoretical model. These results strongly hint at the existence of
interplay between the magnetic properties of chiral phonons and the topology of
electronic band structure.Comment: 6 pages, 3 figures, see Supplemental Material in the Ancillary
director
Magnetic Control of Soft Chiral Phonons in PbTe
PbTe crystals have a soft transverse optical phonon mode in the terahertz frequency range, which
is known to efficiently decay into heat-carrying acoustic phonons, resulting in anomalously low ther-
mal conductivity. Here, we studied this phonon via polarization-dependent terahertz spectroscopy.
We observed softening of this mode with decreasing temperature, indicative of incipient ferroelectric-
ity, which we explain through a model including strong anharmonicity with a quartic displacement
term. In magnetic fields up to 25 T, the phonon mode splits into two modes with opposite hand-
edness, exhibiting circular dichroism. Their frequencies display Zeeman splitting together with an
overall diamagnetic shift with increasing magnetic field. Using a group-theoretical approach, we
demonstrate that these observations are the result of magnetic field-induced morphic changes in the
crystal symmetries through the Lorentz force exerted on the lattice ions. Our study thus reveals a
novel process of controlling phonon properties in a soft ionic lattice by a strong magnetic field.This research was primarily sup-
ported by the National Science Foundation through the
Center for Dynamics and Control of Materials: an
NSF MRSEC under Cooperative Agreement No. DMR-
1720595. F.G.G.H. acknowledges financial support from
the Brasil@Rice Collaborative Grant, the So Paulo Re-
search Foundation (FAPESP) Grants No. 2015/16191-5
and No. 2018/06142-5, and Grant No. 307737/2020-9
of the National Council for Scientific and Technological
Development (CNPq). M. R-V. was supported by LANL
LDRD Program and by the U.S. Department of Energy,
Office of Science, Basic Energy Sciences, Materials Sci-
ences and Engineering Division, Condensed Matter The-
ory Program. G. A. F. acknowledges additional support
from NSF DMR-1949701 and NSF DMR-2114825. J. T.
and I. K. acknowledge the support from the Japan Soci-
ety for the Promotion of Science (JSPS) (KAKENHI No.
20H05662).Center for Dynamics and Control of Material
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial
Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials.
Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure.
Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen.
Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049
Transport properties of silicon implanted with bismuth
The Hall effect and resistivity of Si:Bi with donor concentration varying from 3.0X1017 to 1.4X1020 cm-3 were measured from room temperature down to 13 K. The samples were prepared by Bi1 implantation in Van der Pauw structures delineated in Si chips. The measured resistivities were compared with the ones calculated by a generalized Drude approach at similar temperatures and doping concentration, presenting fairly good agreement. The critical impurity concentration Nc of the metal-nonmetal transition was measured to be around 2X1019 cm-3. The critical concentration Nc was calculated by comparing the ionization energy of the insulating phase with the total energy of the metallic phase. This value of Nc agreed very well with the one obtained experimentally and the values estimated from other theoretical approaches
Transport properties of silicon implanted with bismuth
The Hall effect and resistivity of Si:Bi with donor concentration varying from 3.0X1017 to 1.4X1020 cm-3 were measured from room temperature down to 13 K. The samples were prepared by Bi1 implantation in Van der Pauw structures delineated in Si chips. The measured resistivities were compared with the ones calculated by a generalized Drude approach at similar temperatures and doping concentration, presenting fairly good agreement. The critical impurity concentration Nc of the metal-nonmetal transition was measured to be around 2X1019 cm-3. The critical concentration Nc was calculated by comparing the ionization energy of the insulating phase with the total energy of the metallic phase. This value of Nc agreed very well with the one obtained experimentally and the values estimated from other theoretical approaches
Magnetic and structural properties of Fe-implanted cubic GaN
In this article, we report on structural and magnetic properties of cubic GaN epitaxial layers implanted with Fe ions and subsequently subjected to thermal annealing. The epitaxial quality of the layers was studied by X-ray diffraction rocking curves (x-scans) and Raman spectroscopy. The results show that the implantation damages the crystal structure producing an expansion of the lattice parameter in the implanted region. These damages are partially removed by the thermal treatment. Room temperature ferromagnetism is observed for the sample implanted with a dose of 1.2 1016cm 2, while samples implanted with 2.4 1016cm 2 show a coexistence of ferromagnetism and paramagnetism due to disperse Fe3þ. Thermal annealing changes these magnetic properties. For the low dose sample, the ferromagnetism is converted into paramagnetism while for the high dose we observed an enhancement of the ferromagnetic contribution characterized by a superparamagnetism behavior attributed to Fe-based particles. Published by AIP Publishing